Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New horizons in pharmaceutical technology.

D M Kirking

    The Annals of the American Academy of Political and Social Science
    |June 10, 1983
    PubMed
    Summary
    This summary is machine-generated.

    New drug technologies offer improved effectiveness and safety but raise concerns about optimal prescribing and distribution. Policy must balance drug costs with their potential to reduce overall healthcare expenses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Relationship between patient and disease characteristics, and health-related quality of life in adults with asthma.

    Respiratory medicine·2002
    Same author

    Perspectives on generic pharmaceuticals: some conclusions.

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2002
    Same author

    Understanding the scientific issues embedded in the generic drug approval process.

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2002
    Same author

    Drug product selection: legal issues.

    Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2002
    Same author

    The effect of insurance coverage changes on drug utilization in HIV disease.

    Journal of acquired immune deficiency syndromes (1999)·2001
    Same author

    Compliance from self-reported versus pharmacy claims data with metered-dose inhalers.

    The Annals of pharmacotherapy·2001
    Same journal

    Access to Health Insurance and Health Care for Hispanic Children in the United States.

    The Annals of the American Academy of Political and Social Science·2026
    Same journal

    Skill building in early care and education programs.

    The Annals of the American Academy of Political and Social Science·2025
    Same journal

    Who Goes Next? The Gendered Expansion of Mexican and Senegalese Migrant Sibling Networks in Space and Time.

    The Annals of the American Academy of Political and Social Science·2025
    Same journal

    The Opioid Crisis and Child Maltreatment Across Counties and Time in the United States, 2007-2017.

    The Annals of the American Academy of Political and Social Science·2024
    Same journal

    Who Uses the Social Safety Net? Trends in Public Benefit Use among American Households with Children, 1980-2020.

    The Annals of the American Academy of Political and Social Science·2024
    Same journal

    Adolescents' Analyses of Digital Media Related to Race and Racism in the 2020 U.S. Election: An Assessment of Their Needs and Skills.

    The Annals of the American Academy of Political and Social Science·2024
    See all related articles

    Area of Science:

    • Pharmacology and Health Economics
    • Drug Development and Policy Analysis

    Background:

    • Pharmaceuticals are a primary treatment modality, despite accounting for less than 10% of healthcare expenditures.
    • The total cost of drugs is significant due to adverse effects, misprescribing, and misuse.
    • The 1980s are poised for a surge in new drugs and novel drug delivery systems.

    Purpose of the Study:

    • To address the challenges posed by emerging drug technologies.
    • To explore optimal strategies for prescribing, distribution, financing, and utilization of new pharmaceuticals.
    • To guide future drug development towards therapies with significant advantages over existing options.

    Main Methods:

    • Analysis of drug benefits, costs, and adverse effects.
    • Review of emerging drug delivery technologies and their implications.

    Related Experiment Videos

  • Consideration of policy frameworks for rational drug use and development.

    • Main Results:

    • New drug technologies aim for increased effectiveness, reduced adverse effects, and simpler dosing.
    • Significant questions arise regarding the optimal management of these advanced pharmaceutical products.
    • Ensuring continued innovation in drug technology is crucial for therapeutic advancement.

    Conclusions:

    • Rational drug policy must encompass not only direct drug costs but also their impact on overall healthcare expenditure.
    • Strategic planning is essential to direct drug technology growth towards significant therapeutic improvements.
    • Balancing innovation with cost-effectiveness and safety is key for future pharmaceutical development.